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Edoardo Maragliano (1849-1940) was born in Genoa 
on 1 June 1849 into a family of Ligurian origin. Having 
studied classics, first at the “Ginnasio” of the Padri 
Scolopi and then at high school, he matriculated at the 
Faculty of Medicine of the University of Genoa. After 
his first years of study, he moved to Naples, where he 
completed his course in medicine, graduating with full 
marks in 1870.
In Naples, he was initially a pupil of Prof. Salvatore 
Tommasi (1813-1888) and Prof. Arnaldo Cantani 
(1837-1893). Subsequently, on returning to Genoa, he 
became an assistant to Errico de Rienzi (1839-1921), 
the director of the Medical Clinic, and in 1877 was 
appointed to teach General Pathology, which he did until 
1881 [1]. Indeed, in that year, he was appointed Ordinary 
Professor of Clinical Medicine in Genoa, a position 
he held until 1924. During his tenure, his department 
became a significant point of reference in medical field. 
Maragliano was an indefatigable scholar and a prolific 
author, publishing 2453 scientific works of notable 
importance. Among his main publications, his “Trattato 
delle malattie dei polmoni” (Treatise on lung diseases) 
and his original monographs on nephritis, fever and 
blood are worth mentioning. 
In the present article, we will discuss his contribution to 
the study of tuberculosis (TB) and the immunity elicited 
by infection with Mycobacterium tuberculosis and by 
anti-tuberculosis vaccination.
From 1890 onwards, Maragliano devoted much of his 
research to studying immunity towards tuberculosis 
infection. As an astute pioneer in this field, in 1900 
he founded an innovative institute for the study of 
tuberculosis and infectious diseases: the Maragliano 
Institute in Genoa (Italy). At the end of the 19th century, 
the existence of immunity to tuberculosis was not yet 
recognized; it was claimed that TB was an infection” sui 
generis”, different from others, and the notion that a state 
of immunity could be elicited in humans was rejected. 
Maragliano was the first to cast doubt on this idea and 
demonstrated that it was indeed possible to immunize 
people against TB, just like any other infectious disease.
In order to fully understand Edoardo Maragliano’s 
work, we need to go back to the period immediately 
following the discovery of the TB bacillus by Robert 
Koch (1843-1910) [2].
 In 1882, although immunology was only in its infancy, 
it was already known that any substance introduced 
into a biological system displayed antigenicity 
(immunogenicity), that is to say, the antigen induced 
the production of antibodies, which then mounted 
an immune response. Erroneously, however, it was 
believed that antigenicity was a property intrinsic to any 
substance, such as its molecular weight or its absorption 
spectrum, for example. Based on these assumptions, 
many researchers believed that they could obtain a 
protective immune response by inoculating bacterial 
matter into an animal, without taking into account its 
quantity, and the conditions and mode of inoculation. 
These researchers, however, saw their hopes dashed, so 
much so that and as a consequence of their, owing to the 
failure in demonstrating the immunogenicity of the TB 
bacillus, they concluded that it would never be possible 
to create a vaccine against TB [3]. 
This was the state of research between 1884 and the 
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early 1890s. By then, Maragliano had been running the 
Medical Clinic in Genoa for a decade where he promoted 
the study and understanding the immunogenicity of 
Mycobacterium tuberculosis”. Nevertheless, his stance 
was not that of the pure bacteriologist, but rather that of 
the physician who remained focused on the patient [4]. 
Maragliano needed to demonstrate the antigenicity of 
the TB bacillus experimentally in an animal model. To 
prove the immunogenicity of the bacillus, Maragliano 
adopted the following stratagems:
1. Firstly, it was necessary to calibrate the intensity of 
the bacterial load very carefully; i.e., the right amount 
had to be inoculated: neither too much nor too little. 
In order to trigger a defensive movement, Maragliano 
claimed that the “offended cells” had to react. If, 
however, the “offense” were too strong, the ability to 
react would be weakened and eventually arrested;
2. Secondly, the gradual appearance of antibodies and 
the disappearance of the bacilli had to be monitored, 
in order to determine when the immune response had 
reached its peak (maximum development). According 
to Maragliano, this should generally occur around 
the 90th day after inoculation;
3. Thirdly, only after respecting this timing could 
the animal be tested to determine whether it was 
capable of “defending itself”; i.e., of reacting to a 
new bacterial load that was equal to the smallest 
load that would be able to kill a control animal. In 
Maragliano’s view, this last precaution was not only 
indespensable for the experiment to be successful; it 
also explained why the tests conducted without these 
stratagems had failed [5].
The stratagems implemented by Maragliano led to the 
development of anti-tuberculosis vaccination: not only 
that of the Professor himself, the “Vaccino Maragliano”, 
but also of all those that were to follow [6].
Indeed, Maragliano’s greatest merit probably lies in the 
fact that he was the first to introduce what he himself 
called “stratagems”; this was confirmed in his farewell 
lesson on 28 June 1924 (7) after 43 years of teaching, in 
which he clearly stated:
“Here, on this solemn occasion, it behooves me to 
make a declaration. The therapeutic applications of 
our studies and the specific therapy that has sprung 
from those studies are of secondary importance. Indeed, 
what constitutes the chief boast of our School is the 
discovery of a series of stratagems which demonstrated 
the existence of an immunogenicity of the bacillus that 
was functionally dependent on the biological system and 
the conditions used”.
These “stratagems” worked out by Maragliano concerning 
Mycobacterium tuberculosis must, still today, be borne in 
mind in the case of any other antigen. Indeed, in every 
immunology textbook, we always find the concept that 
the formation of antibodies does not depend only on the 
inoculation of the antigen into a suitable animal, but also 
on other conditions, such as, for example, the quantity and 
quality of the antigen injected, the route of inoculation, 
the immune status of the subject, and the frequency of the 
various follow-up tests.
Indeed, the principal merit of the school directed by 
Prof. Edoardo Maragliano, as he himself pointed out in 
his farewell lesson, was “… having discovered a series 
of facts that demonstrated the existence of a tubercular 
immunity, which had hitherto been denied, and having 
laid the foundations of the new conceptions of the 
pathology of tubercular diseases, conceptions which are 
now all based on immunity” (6).
As the great scientist Saturnin Arloing (1846-1911) 
publicly stated in 1906 in Genoa, in a speech on 
Maragliano’s studies: “Until 1895, we despaired of 
being able to obtain tubercular immunity. Through his 
discoveries, Maragliano raised the spirits of researchers 
from the depths of despondency into which they had 
fallen. At first, the announcement was greeted with 
reservation, but then confirmation came from all sides: 
what he had said was true. This was the first word of 
“serene justice” that our school received from the 
scientific community, and it emanated from a scientist of 
international eminence”[8].
Maragliano actively contributed to the still ongoing 
process of understanding the difficult interaction between 
Mycobacterium tuberculosis and the host [9,10]. 
Even today we must always observe and emphasize that 
infection prevention and control measures are particularly 
important in public health facilities because there is 
a risk of transmission of the tuberculosis bacterium 
“Mycobacterium tuberculosis”; the World Health 
Organization (WHO) developed recommendations 
according to the methods defined in the WHO handbook 
for guideline development [11].
Moreover, we should always consider and reflect on one 
Fig. 1. Prof. Edoardo Maragliano (1849-1940) (Wikipedia Com-
mons).
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of the most important aspects in this long pathway: a real 
and successful vaccine.
We still have to remember today that only a really 
efficacious vaccine will enable us to eradicate TB.
According to the World Health Organization, tuberculosis 
(TB) is the leading cause of death from infectious disease 
worldwide (WHO, 2017). While there is no effective 
vaccine against adult pulmonary TB, more than a dozen 
vaccine candidates are in the clinical trial pipeline [12].
But how long will we still have to wait? 
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